Barboza EMA, Barboza CKD

Language: Spanish
References: 16
Page: 67-74
PDF size: 162.51 Kb.

ABSTRACT

Background and objectives: Platelet antiagregation is one of the main beneficial therapeutic measures in the secondary prevention of ischemic stroke. This review aims to analyze the recommendations and current evidence regarding the most studied antiplatelet therapies. Results: antiplatelet therapy with aspirin on the first 24 hours of the beginning of the event has a strong recommendation in the reduction of the risk of death and recurrent cerebrovascular events. Dual antiplatet therapy with the strongest evidence for secondary prevention accounts for dipyridamole plus aspirin, and aspirin plus clopidogrel (superiority on efficay and safety against monotherapy mainly on the first 30 days after stroke).

REFERENCES

1. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patient at risk of ischaemic events (CAPRIE). Lancet 1996; 348:1329-39

2. Dengler R, Diener HC, Schwartz A, Grond M. Early treatment with aspirin plus extended-release dypiridamole for transient ischaemic attack or ischemic stroke within 24h of symptom onset (EARLY trial): a randomized, open-label, blinded-endpoint trial. Lancet Neurology 2010; 9:159-66

3. Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high risk-patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 2004; 364:331-337.

4. Diener HC, Cunha L, Forbes C, Sivenius J et al. European stroke prevention study 2: dypiridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143:1-13

5. James G. Antiplatelet Therapy after Ischemic Stroke or TIA. N Engl J Med 2018; DOI: 10.1056/NEJMe1806043.

6. Jauch E, Saver J, Adams H, Bruno A et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professional from the American Heart Association/American Stroke Association. Stroke 2013; 44:870-947.

7. Johnston SC, Amarenco P, Albers GW, et al. Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med 2017; 375:35-43

8. Johnston SC, Easton D, Farrant M, Barsan W, Conwit R, Elm J, et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT). N Engl J Med 2018; DOI: 10.1056/NEJMoa1800410

9. Gouya G, Arrich J, Wolzt M, Huber K et al. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases. Stroke 2014; 45:492-503

10. Halkes PH, Van Gljn J, Kappelle LJ, Koudstaal PJ et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemic of arterial origin (ESPRIT): randomized controlled trial. Lancet 2006;367:1665-73

11. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M et al; FASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol. 2007; 6:961–969.

12. Kernan W, Ovbiagele B, Balck H, Bravata D, Chimowitz M, Ezekowitz M, et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke 2014; 45:2160-2236.

13. Liu Y, Fei Z, Wang W, Fang J, Zou M, Cheng G. Efficacy and safety of short-term dual- versus mono-antiplatelet therapy in patients with ischemic stroke or TIA: a meta-analysis of 10 randomized controlled trials. J Neurol. 2016;263:2247-59

14. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke. A guideline for healthcare professionals from the American Heart Association/American Stoke Association. Stroke 2018;49:eDOI: 10.1161/STR.0000000000000158

15. The SPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012; 367:817-25

16. Wang Y, Wang Y, Zhao X, Liu L et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013; 369:11-1974